Safety, tolerability, pharmacokinetics and pharmacodynarnics of SK-0403, a novel DPP-IV inhibitor, in healthy Japanese subjects

被引：0
|
作者：
Sunami, Yukiko
Yoshioka, Naoya
Hayashi, Ichiro
Ishida, Tsutomu
Ishida, Tomu
机构：
来源：
DIABETES | 2007年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A128 / A129
页数：2
相关论文
共 50 条
  • [21] Multiple dose administration of MK-0431, a dipeptidyl peptidase IV (DPP-IV) inhibitor, in healthy male subjects
    Bergman, A
    Stevens, C
    Zhou, YY
    Laethem, M
    Lachaert, R
    Snyder, K
    Hilliard, DR
    Tanaka, W
    Zeng, W
    Wang, A
    Chen, L
    Winchell, G
    Ramael, S
    Davies, M
    Wagner, J
    Herman, G
    DIABETES, 2005, 54 : A506 - A506
  • [22] Pharmacokinetics, safety, and tolerability of ceftolozane/tazobactam in healthy Japanese, Chinese, and white subjects
    Aiudi, Anthony
    Miller, Benjamin
    Krishna, Gopal
    Adedoyin, Adedayo
    Xiao, Alan
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2016, 30 (06) : 625 - 633
  • [23] Pharmacokinetics, safety and tolerability of mipomersen in healthy Japanese volunteers and comparison with Western subjects
    Li, Zhaoyang
    Hard, Marjie L.
    Andersen, Grit
    Pabst, Guenther
    Wagener, Gilbert
    Singh, Tejdip
    Chin, Wai
    Culm-Merdek, Kerry
    Boltje, Ingrid
    von Moltke, Lisa L.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2014, 52 (04) : 314 - 320
  • [24] Pharmacokinetics, Safety and Tolerability of Rotigotine Transdermal Patch in Healthy Japanese and Caucasian Subjects
    Cawello, Willi
    Kim, Seong R.
    Braun, Marina
    Elshoff, Jan-Peer
    Ikeda, Junji
    Funaki, Tomoo
    CLINICAL DRUG INVESTIGATION, 2014, 34 (02) : 95 - 105
  • [25] Galantamine pharmacokinetics, safety, and tolerability profiles are similar in healthy Caucasian and Japanese subjects
    Zhao, QY
    Brett, M
    Van Osselaer, N
    Huang, FL
    Raoult, A
    Van Peer, A
    Verhaeghe, T
    Hust, R
    JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (09): : 1002 - 1010
  • [26] Pharmacokinetics, Safety and Tolerability of Rotigotine Transdermal Patch in Healthy Japanese and Caucasian Subjects
    Willi Cawello
    Seong R. Kim
    Marina Braun
    Jan-Peer Elshoff
    Junji Ikeda
    Tomoo Funaki
    Clinical Drug Investigation, 2014, 34 : 95 - 105
  • [27] Pharmacokinetics, Pharmacodynamics, Pharmacogenomics, Safety, and Tolerability of Avatrombopag in Healthy Japanese and White Subjects
    Nomoto, Maiko
    Pastino, Gina
    Rege, Bhaskar
    Aluri, Jagadeesh
    Ferry, Jim
    Han, David
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2018, 7 (02): : 188 - 195
  • [28] Safety, tolerability and pharmacokinetics of udenafil, a novel PDE-5 inhibitor, in healthy young Korean subjects
    Kim, Bo-Hyung
    Lim, Hyeong-Seok
    Chung, Jae-Yong
    Kim, Jung-Ryul
    Lim, Kyoung Soo
    Sohn, Dong-Ryul
    Cho, Joo-Youn
    Yu, Kyung-Sang
    Shin, Sang-Goo
    Paick, Jae-Seung
    Jang, In-Jin
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 65 (06) : 848 - 854
  • [29] Pharmacokinetic interaction study between metformin and a novel dipeptidyl peptidase-IV (DPP-IV) inhibitor PSN9301 in healthy subjects.
    Boinpally, R. R.
    Wolf, J.
    Savell, A.
    Clark, G.
    Hamilton, M.
    Rachman, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S106 - S106
  • [30] A randomized study investigating the safety, tolerability, and pharmacokinetics of evinacumab, an ANGPTL3 inhibitor, in healthy Japanese and Caucasian subjects
    Harada-Shiba, Mariko
    Ali, Shazia
    Gipe, Daniel A.
    Gasparino, Evelyn
    Son, Vladimir
    Zhang, Yi
    Pordy, Robert
    Catapano, Alberico L.
    ATHEROSCLEROSIS, 2020, 314 : 33 - 40
12345